Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07841366

Compairing Micro Needling With Phenytoin Versus Microneedling Alone on Striae Alba

Conditions: Treatment of Striae Alba

Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Al-Azhar University

Location: Al-Azhar University, Faculty of Medicine for Girls Cairo Cairo Governorate

Summary

The aim of this study is to evaluate the efficacy and safety of Microneedling with Phenytoin versus Microneedling alone for the Treatment of Striae alba.The study is a comparative study which will be carried on 30 patients with Striae alba. Each patient will receive four sessions three weeks apart of the following treatment: -Right side: striae on the right side will be treated by microneedling with depth (2 mm)with topical phenytoin 2% solution. -Left side: striae on the left side will be treated by microneedling alone with depth (2 mm) . The follow up will be during each session and 1 months after the last session. For treated striae alba, Microneedling will be done under aseptic conditions using isopropyl alcohol 70%.

Eligibility Criteria

Inclusion Criteria: * Patients with stria alba. * The patient's age ≥18 years. * Both sex male and Femal patients * At least 3 stria Exclusion Criteria: * Pregnancy or lactation. * Keloid or hypertrophic scar tendency * Active skin infection at treatment site * Use of isotretinoin within the past 6 months * Bleeding disorders or anticoagulant therapy * History of hypersensitivity to phenytoin * Chronic systemic diseases affecting wound healing (e.g., uncontrolled diabetes) * Previous striae treatment within the last 6 months * Unrealistic expectations or poor compliance * Premalignant or malignant lesions in the treatment area

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07841366). StuddyBuddy aggregates publicly available trial information.